G

Genprex
D

GNPX

0.28400
USD
0.01
(2.20%)
مغلق
حجم التداول
6,592
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
6,859,409
أصول ذات صلة
G
GNFT
0.49000
(13.76%)
4.05000 USD
G
GNSS
-0.03000
(-1.40%)
2.11000 USD
المزيد
الأخبار المقالات

العنوان: Genprex

القطاع: Healthcare
الصناعة: Biotechnology
Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for largepatient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.